1,337 results on '"Cortese, Bernardo"'
Search Results
2. Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry
3. Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison
4. Balón liberador de sirolimus en el tratamiento del síndrome coronario agudo y crónico: el estudio PEACE, un subanálisis del registro EASTBOURNE
5. Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry
6. Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study
7. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry
8. Clinical outcomes of a dedicated bifurcation stent system
9. Performance of sodium-glucose cotransporter 2 inhibitors in cardiovascular disease
10. Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: Post hoc analysis from the prospective EASTBOURNE registry
11. Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A subanalysis of the EASTBOURNE study
12. A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels
13. Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score
14. Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM)
15. A Clinical Appraisal of Optical Coherence Tomography for Left Main Stem Intervention
16. Is There a Role for OCT for Left Main Assessment Before and After PCI?
17. Comparison of Outcomes Between 1- and 2-Stent Techniques for Medina Classification 0.0.1 Coronary Bifurcation Lesions
18. Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome
19. Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry
20. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up
21. IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry
22. mTOR Inhibition by Drug-Coated Balloon
23. Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions
24. Small Vessel Coronary Artery Disease: Rationale for Standardized Definition and Critical Appraisal of the Literature
25. Long-term benefits of drug-coated balloons for coronary artery revascularization.
26. Magic Touch sirolimus-coated balloon: animal and clinical evidence of a coronary sirolimus drug-coated balloon.
27. Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registry.
28. The role of drug-coated balloons for coronary bifurcation management: results from the prospective EASTBOURNE-BIF study.
29. Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis—DM-Dragon Registry.
30. Previous Mistakes with DCB Technology, and How to Prevent Them in the Future
31. The Use of Drug-Coated Balloons for Patients with In-Stent Restenosis
32. Cost/Effectiveness and Reimbursement Policies with Drug-Coated Balloons in Europe
33. History of Drug-Coated Balloons
34. Drug-Coated Balloons for Native Femoro-popliteal Disease
35. Dissection Management with Drug-Coated Balloons
36. Sirolimus-Coated Balloon: Insights on a New Technology for Coronary Use
37. Drug-Coated Balloons in Native Coronary Artery Disease
38. Balón recubierto con sirolimus por el tratamiento del síndrome coronario agudo y crónico: subanálisis del estudio EASTBOURNE
39. Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels
40. Drug-coated balloons on the �big stage�: is this technology ready for an all-comer population with de novo lesions?
41. A 2024 scientific update on the clinical performance of drug-coated balloons
42. Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry)
43. Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry)
44. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
45. A Prospective Multicenter Randomized Trial to Assess the Effectiveness of the MagicTouch Sirolimus-Coated Balloon in Small Vessels: Rationale and Design of the TRANSFORM I Trial
46. Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial
47. IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: The SMILE Registry
48. Are we at dawn of the drug-coated balloons era? Current evidence, future directions, and tasks of the newly established working group of the Association of Cardiovascular Interventions.
49. Coronary stent failure: role of a blended approach with drug-coated balloons for complex lesions.
50. Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.